These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 33103382

  • 1. Reduction in flippase activity contributes to surface presentation of phosphatidylserine in human senescent erythrocytes.
    Seki M, Arashiki N, Takakuwa Y, Nitta K, Nakamura F.
    J Cell Mol Med; 2020 Dec; 24(23):13991-14000. PubMed ID: 33103382
    [Abstract] [Full Text] [Related]

  • 2. ATP11C is a major flippase in human erythrocytes and its defect causes congenital hemolytic anemia.
    Arashiki N, Takakuwa Y, Mohandas N, Hale J, Yoshida K, Ogura H, Utsugisawa T, Ohga S, Miyano S, Ogawa S, Kojima S, Kanno H.
    Haematologica; 2016 May; 101(5):559-65. PubMed ID: 26944472
    [Abstract] [Full Text] [Related]

  • 3. ATP11C T418N, a gene mutation causing congenital hemolytic anemia, reduces flippase activity due to improper membrane trafficking.
    Arashiki N, Niitsuma K, Seki M, Takakuwa Y, Nakamura F.
    Biochem Biophys Res Commun; 2019 Aug 27; 516(3):705-712. PubMed ID: 31253392
    [Abstract] [Full Text] [Related]

  • 4. Maintenance and regulation of asymmetric phospholipid distribution in human erythrocyte membranes: implications for erythrocyte functions.
    Arashiki N, Takakuwa Y.
    Curr Opin Hematol; 2017 May 27; 24(3):167-172. PubMed ID: 28118222
    [Abstract] [Full Text] [Related]

  • 5. An Unrecognized Function of Cholesterol: Regulating the Mechanism Controlling Membrane Phospholipid Asymmetry.
    Arashiki N, Saito M, Koshino I, Kamata K, Hale J, Mohandas N, Manno S, Takakuwa Y.
    Biochemistry; 2016 Jun 28; 55(25):3504-3513. PubMed ID: 27267274
    [Abstract] [Full Text] [Related]

  • 6. A novel missense variant in ATP11C is associated with reduced red blood cell phosphatidylserine flippase activity and mild hereditary hemolytic anemia.
    van Dijk MJ, van Oirschot BA, Harrison AN, Recktenwald SM, Qiao M, Stommen A, Cloos AS, Vanderroost J, Terrasi R, Dey K, Bos J, Rab MAE, Bogdanova A, Minetti G, Muccioli GG, Tyteca D, Egée S, Kaestner L, Molday RS, van Beers EJ, van Wijk R.
    Am J Hematol; 2023 Dec 28; 98(12):1877-1887. PubMed ID: 37671681
    [Abstract] [Full Text] [Related]

  • 7. Identification and functional analyses of disease-associated P4-ATPase phospholipid flippase variants in red blood cells.
    Liou AY, Molday LL, Wang J, Andersen JP, Molday RS.
    J Biol Chem; 2019 Apr 26; 294(17):6809-6821. PubMed ID: 30850395
    [Abstract] [Full Text] [Related]

  • 8. Mice deficient in the putative phospholipid flippase ATP11C exhibit altered erythrocyte shape, anemia, and reduced erythrocyte life span.
    Yabas M, Coupland LA, Cromer D, Winterberg M, Teoh NC, D'Rozario J, Kirk K, Bröer S, Parish CR, Enders A.
    J Biol Chem; 2014 Jul 11; 289(28):19531-7. PubMed ID: 24898253
    [Abstract] [Full Text] [Related]

  • 9. Caspase-mediated cleavage of phospholipid flippase for apoptotic phosphatidylserine exposure.
    Segawa K, Kurata S, Yanagihashi Y, Brummelkamp TR, Matsuda F, Nagata S.
    Science; 2014 Jun 06; 344(6188):1164-8. PubMed ID: 24904167
    [Abstract] [Full Text] [Related]

  • 10. The ratio of ATP11C/PLSCR1 mRNA transcripts has clinical significance in sickle cell anemia.
    Pereira-Martins DA, Coelho-Silva JL, Domingos IF, Weinhäuser I, Franca-Neto PL, Araujo AS, Franca RF, Bezerra MA, Lucena-Araujo AR.
    Ann Hematol; 2022 Feb 06; 101(2):281-287. PubMed ID: 34651249
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Flippase and scramblase for phosphatidylserine exposure.
    Nagata S, Sakuragi T, Segawa K.
    Curr Opin Immunol; 2020 Feb 06; 62():31-38. PubMed ID: 31837595
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of flippase-like activity by tubulin regulates phosphatidylserine exposure in erythrocytes from hypertensive and diabetic patients.
    Muhlberger T, Balach MM, Bisig CG, Santander VS, Monesterolo NE, Casale CH, Campetelli AN.
    J Biochem; 2021 Sep 07; 169(6):731-745. PubMed ID: 33576821
    [Abstract] [Full Text] [Related]

  • 17. ATP11C Facilitates Phospholipid Translocation across the Plasma Membrane of All Leukocytes.
    Yabas M, Jing W, Shafik S, Bröer S, Enders A.
    PLoS One; 2016 Sep 07; 11(1):e0146774. PubMed ID: 26799398
    [Abstract] [Full Text] [Related]

  • 18. Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes.
    Chung SM, Bae ON, Lim KM, Noh JY, Lee MY, Jung YS, Chung JH.
    Arterioscler Thromb Vasc Biol; 2007 Feb 07; 27(2):414-21. PubMed ID: 17110600
    [Abstract] [Full Text] [Related]

  • 19. Stimulation of erythrocyte phosphatidylserine exposure by chlorpromazine.
    Akel A, Hermle T, Niemoeller OM, Kempe DS, Lang PA, Attanasio P, Podolski M, Wieder T, Lang F.
    Eur J Pharmacol; 2006 Feb 17; 532(1-2):11-7. PubMed ID: 16472802
    [Abstract] [Full Text] [Related]

  • 20. Tanshinone IIA stimulates erythrocyte phosphatidylserine exposure.
    Zelenak C, Pasham V, Jilani K, Tripodi PM, Rosaclerio L, Pathare G, Lupescu A, Faggio C, Qadri SM, Lang F.
    Cell Physiol Biochem; 2012 Feb 17; 30(1):282-94. PubMed ID: 22759974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.